Effect of tofacitinib on clinical and laboratory findings in severe and resistant patients with COVID-19

CONCLUSIONS: The administration of tofacitinib combined with corticosteroids, is not effective enough to treat severe COVID-19 patients and the use of this medication should be considered before the disease deterioration.PMID:37454635 | DOI:10.1016/j.intimp.2023.110565

Source: International Immunopharmacology - July 16, 2023 Category: Allergy & Immunology Authors: Simin Almasi Azadeh Rashidi Manizhe Ataee Kachuee Bentolhoda Mohammad Shirazi Shirin Izadi Sara Ghaffarpour Mehdi Azimi Mohammad Mehdi Naghizadeh Mahin Jamshidi Makiani Mitra Ranjbar Manizheh Goudarzi Neda Rahimian Tooba Ghazanfari Source Type: research